Atlas Trials

Ketamine for Major Depressive Disorder

Clinical trial NCT03721900 · UNKNOWN

Trial details

NCT number
NCT03721900
Sponsor
Shenox Pharmaceuticals, LLC
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Major Depressive Disorder
Start date
2018-12-28
Primary completion
2019-06-06
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.